These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8975873)

  • 1. Effect of interferon-gamma, in vitro and in vivo, on mRNA levels of phagocyte oxidase components.
    Weening RS; de Klein A; de Boer M; Roos D
    J Leukoc Biol; 1996 Dec; 60(6):716-20. PubMed ID: 8975873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components.
    Cassatella MA; Bazzoni F; Flynn RM; Dusi S; Trinchieri G; Rossi F
    J Biol Chem; 1990 Nov; 265(33):20241-6. PubMed ID: 2173701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
    Condino-Neto A; Newburger PE
    Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon gamma-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc gamma R-I) in human polymorphonuclear leukocytes.
    Amezaga MA; Bazzoni F; Sorio C; Rossi F; Cassatella MA
    Blood; 1992 Feb; 79(3):735-44. PubMed ID: 1531037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD).
    Jackson SH; Miller GF; Segal BH; Mardiney M; Domachowske JB; Gallin JI; Holland SM
    J Interferon Cytokine Res; 2001 Aug; 21(8):567-73. PubMed ID: 11559434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
    Ahlin A; Elinder G; Palmblad J
    Blood; 1997 May; 89(9):3396-401. PubMed ID: 9129047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of interferon-gamma therapy in chronic granulomatous disease.
    Errante PR; Frazão JB; Condino-Neto A
    Recent Pat Antiinfect Drug Discov; 2008 Nov; 3(3):225-30. PubMed ID: 18991804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental expression of NADPH phagocytic oxidase components in mouse embryos.
    Baehner RL; Millar-Groff S; Bringas P
    Pediatr Res; 1999 Aug; 46(2):152-7. PubMed ID: 10447107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
    Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
    Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.
    Chu J; Song HH; Zarember KA; Mills TA; Gallin JI
    J Immunol; 2013 Sep; 191(6):3297-307. PubMed ID: 23956436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype.
    Ambruso DR; Briones NJ; Baroffio AF; Murphy JR; Tran AD; Gowan K; Sanford B; Ellison M; Jones KL
    PLoS One; 2022; 17(2):e0263370. PubMed ID: 35113934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human polymorphonuclear leukocytes.
    Cassatella MA; Bazzoni F; Calzetti F; Guasparri I; Rossi F; Trinchieri G
    J Biol Chem; 1991 Nov; 266(33):22079-82. PubMed ID: 1834666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood.
    Gallin JI
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S100-5. PubMed ID: 1934607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.